Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
P1.14-61 EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions
PaperCitations, authors & open-access status
P1.14-61 EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2019 year and bronze oa status.
1
Citations
2019
Year
bronze
OA Status